Digestive & Intestinal Remedies (Pharmacies) - Eastern Africa

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$119.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.04%, resulting in a market volume of US$152.60m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.26 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Eastern Africa is experiencing steady growth due to various factors. Customer preferences in the region are shifting towards a more health-conscious lifestyle, leading to an increased demand for digestive and intestinal remedies. As people become more aware of the importance of gut health, they are seeking out products that can alleviate digestive issues and promote overall well-being. Additionally, the rising prevalence of gastrointestinal disorders, such as irritable bowel syndrome and acid reflux, is driving the demand for these remedies. Trends in the market indicate a growing interest in natural and herbal remedies. Consumers are increasingly opting for products that are made from natural ingredients and do not contain artificial additives or preservatives. This trend is in line with the global shift towards more natural and organic products, as people become more conscious of the potential side effects of synthetic medications. Local special circumstances in Eastern Africa also contribute to the development of the Digestive & Intestinal Remedies market. Traditional medicine plays a significant role in the region, with many people relying on herbal remedies and traditional healing practices. This cultural preference for natural remedies aligns with the growing demand for natural digestive and intestinal remedies. Underlying macroeconomic factors, such as population growth and increasing disposable incomes, are also driving the growth of the market. As the population in Eastern Africa continues to grow, so does the potential customer base for digestive and intestinal remedies. Additionally, rising disposable incomes allow consumers to afford these products, further fueling market growth. In conclusion, the Digestive & Intestinal Remedies market in Eastern Africa is developing due to shifting customer preferences towards a health-conscious lifestyle, growing interest in natural and herbal remedies, local cultural preferences for traditional medicine, and underlying macroeconomic factors such as population growth and increasing disposable incomes. This presents opportunities for companies operating in the market to cater to the evolving needs and preferences of consumers in the region.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.